抗体效价(log2) 7 s& Q* b H, S- b: a; g
| 攻毒数
7 S$ A5 q9 }) J& l | 死亡数 6 a! e. `+ e' w1 M% I
| 存活数 8 j! b' k' ~5 @) S
| 保护率%
9 X( e* O$ d& T8 a3 r |
06 M H" a' Z: i0 H/ U. `7 A8 p
| 6
' A9 W6 E4 n* i# w | 6; F( g2 N9 d- b% x Q8 q
| 0( q, Z* z8 A# T+ P; m) o9 R* C5 g
| 0
8 h0 u+ }- s9 j/ [5 O% m. I |
1
2 m# B# b, s( ]: P$ M" F | 6) ^% ~" w0 v' W3 Q6 [( x4 C
| 68 C! N, u5 z {9 V) L6 q! }
| 0! W$ }! j o- u8 ?/ S# k
| 0; K" e& y- g a- }+ l; t
|
2
" C, H* F+ p) Z. U | 6 4 k! a: u4 ?- U& G! M+ @1 r7 o
| 3
" W. _- B% T5 H! N' { | 3 % w/ _7 E+ T& z( V# Y1 c
| 50 & a0 O6 x1 G' C. C
|
3 ( l: F& R* F0 H
| 6
! }5 k7 @3 T. @+ E0 l) T; M | 0 . L# y0 W% j8 [7 e2 \
| 6
6 a7 ?1 n$ O- j8 S7 @ | 100
+ J/ ^, J% C3 y! B Z" J3 N |
4 {3 y# ^& W5 i# C9 n& e9 x
| 6
& {$ z9 p. k( B9 f* }/ N0 W6 Q% N | 0 , j* `; w0 ~: x. g" f! |
| 6
( w6 T9 H2 v* `+ u+ h+ g; z; u | 100 8 V& |; O. u [6 {9 G/ n
|
8 p& C2 v) p5 ^* W1 j" S. |
日龄8 H. z: P6 o: J; A7 q% f
| ; t( T; q/ S: ?: E2 |9 Z
免疫后
" r) F* n& l$ L# ~ r$ e |
1周 . f6 p. P+ U1 q7 P% h
| 2周
' [9 J0 D7 c7 c$ y+ C: i, D+ r3 | | 3周
/ X. b$ \4 K3 p7 X& q | 4周
* _* w! J& ]. f9 V | 5周
9 G0 Y, }$ B5 m | 6周
4 |% f" }: e8 i, E& D1 q | 7周 6 }% M4 N- z" s, e7 J0 y
| 8周
6 j( o! q! ?$ H/ y7 ~ |
30
9 g J% q+ j4 i `' ^ | 1.67±0.58c
4 L! h3 d& _7 U" d3 E. g | 2.75±0.96bc' V' L6 A! M% ~5 k+ ^
| 1.75±0.96b. b2 P5 [& L- E. x& e
| 1.00±0.00d
' D" A( d! |3 A/ j) y | 0.25±0.50c
. i& E4 z& |6 q/ B' } | 0.13±0.25c, r) e6 z- n" N7 r8 U
| 0
/ h3 \0 Y( D3 e. T5 F2 X. a | 0
: E+ u* t) e: C9 U% F* q |
355 k4 `% f/ v0 M& q N5 T
| 3.25±0.50ab0 Q! O, }& I* T3 a# F/ t
| 3.00±0.82bc* R7 t* ]2 f' K$ W( ^6 ], Z+ I5 ^5 [
| 2.38±0.49b. n9 F. Q& v8 a% n" ^
| 2.00±0.00c
; }5 K, P8 @7 H7 U% n3 I0 w | 1.00±0.00c7 b8 V, s: I5 j3 w5 Y. t3 s8 a( t
| 0.75±0.50c
G; p- n' K k3 m! R; q0 {2 K | 07 C- R1 _* X$ v& s
| 0
, Y" j1 S- O1 i- S5 S, r |
40 j9 L1 O8 {! o# q( P# k) C
| 3.00±0.82ab4 \( l( z& i$ l, l. K% e: ^
| 5.75±1.71a3 r- h+ r; f6 l5 a: U% _
| 5.00±1.83a
1 e+ a- x5 S3 y' Y" { | 3.25±1.50b
' |# Q' u, X' y4 m) c$ ^. a | 3.00±0.82b5 ?- l# u9 V0 X( y
| 2.13±0.50b# n2 {) C G) ]5 d: o6 e, Q0 B9 O6 @& p
| 1.83±0.58bc5 k% L5 {3 j3 T9 a
| 1.03±0.63bc
3 v3 ?0 Y, W0 S' |$ G0 l |
45
* h% x9 h6 p; ^* D& `9 s4 Z4 S | 3.25±1.26ab
6 G/ ]/ r& n( n0 _. P4 [. N) ~ | 4.25±0.96ab& b% H/ F5 X. Q n6 J
| 5.50±1.29a) J! T v: @9 @" v: |. T8 W
| 3.75±0.96b( `7 V: X8 c( o1 o3 K* ~
| 3.25±1.26b6 \4 x. H5 R0 b6 }' {% |
| 2.38±1.80b
, C; I, b+ ~' {2 | | 2.00±1.41bc' d+ z" c1 m$ U9 }0 H
| 1.13±0.63bc
- n" N( y( i( [3 K2 s5 n1 o3 U+ I |
509 G' E" t- U# W/ m
| 2.25±0.50bc
! o. T7 f& q* s: L! [$ w | 4.25±0.96ab
! s. J+ {( g: k! X3 x# n) T$ l | 4.50±2.08a0 U5 H' z: x+ p7 C( N
| 5.75±0.50a
" r% R' d! I. H: y | 6.00±0.00a- J. T# B) {" B, ^. V( F
| 5.00±0.00a6 }$ G0 O% L. {& U8 t$ o. x8 K
| 3.5±0.58ab
+ _6 i' ~* C- S: Y5 h | 1.50±0.58b
0 J }( {2 s+ h' [! _ |
55% ?8 H8 Q# J, k- G3 y9 m# v1 ^
| 3.50±0.58a' i' o: T4 q% G: e
| 4.75±0.50a
( `' U7 n; \( f7 E/ [8 p | 6.00±0.82b( a4 g( \' Y- V
| 5.75±1.50a
1 @3 A+ x. @ P/ U2 j | 5.25±0.96a" {9 p# r; K6 v6 E, e* a
| 4.25±0.50a; F8 w3 C0 N/ c' H4 E" B) p
| 3.25±0.96b
/ R0 } r. c* i b- @ | 2.75±1.26ab3 c# M, U' \8 B# n
|
604 e- f: p& y* I5 Y. R, u
| 3.50±0.58a
5 q- b. s+ Q; A | 5.00±0.82a( U) W9 |7 ^, R% }, `
| 6.25±0.50a
: S. y3 i) P& S: E6 m5 X | 5.75±0.96a
7 V* J3 ~ j5 P( T | 5.00±0.82a
2 x6 b( f2 `$ \4 @) h | 4.13±0.85a& r% ~( ` N8 O( a- }1 N
| 3.25±0.96b3 |8 [. t. y6 Z- X1 l% `4 S
| 2.25±0.96b
9 z8 C9 m( z- c4 z( n1 M |